整合ESG支柱在生物制药行业的商业模式创新

IF 1.6 Q3 BUSINESS, FINANCE Australasian Accounting Business and Finance Journal Pub Date : 2023-01-01 DOI:10.14453/aabfj.v17i1.12
A. Bhattacharya, Sonali Bhattacharya
{"title":"整合ESG支柱在生物制药行业的商业模式创新","authors":"A. Bhattacharya, Sonali Bhattacharya","doi":"10.14453/aabfj.v17i1.12","DOIUrl":null,"url":null,"abstract":"The study explores critical factors that impact the Business Model of Biopharmaceutical firms and assess how ESG pillars can aid in Business Model innovation. Semi-structured personal interviews were conducted in face to face meetings with experienced industry professionals from cross-functional domains to attain diverse insights. The objective was to explore the relevance of ESG factors and their interplay, during Business Model Innovation from the perspective of experts in the Biopharmaceutical industry. Analytical Hierarchy Process (AHP) – a structured approach is applied to understand the criticality of various factors in sustainable business models. The study revealed that special emphasis should be laid on the Business Model and Governance Pillar – for re-designing innovative and sustainable business models. Social and Environment factors, although important, were rated lower on priority as such issues are usually focused upon by organizations at a higher level of maturity, after the basic hygiene factors are met. Some of the factors which were prioritized for Business Model innovation are Patient Health and Safety, Ethical marketing and advertising, Waste/ Effluent Management, Employee Health, Safety and Wellness, Patient value propositions, Building strategic resources and competencies, Product Quality & Safety and Business ethics and competitive behavior. Integrated reporting is another value-added dimension that was stressed by the respondents, to have a seamless and transparent communication channel established with all stakeholders. Aligning business metrics with ESG metrics is the focal point of this study, and the impact of each pillar on Biopharma Business Models was evaluated by industry experts. Integration of ESG parameters for Business Model Innovation is the new mantra for forward looking companies, and this study would help frame strategies for the Biopharma industry for sustainable value creation. The impact created by Business Model Innovation at an industry level will help create value for the society at large (who are the key beneficiaries of Biopharma products and services), and such studies would help add to the knowledge base.","PeriodicalId":45715,"journal":{"name":"Australasian Accounting Business and Finance Journal","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Integrating ESG Pillars for Business Model Innovation in the Biopharmaceutical Industry\",\"authors\":\"A. Bhattacharya, Sonali Bhattacharya\",\"doi\":\"10.14453/aabfj.v17i1.12\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The study explores critical factors that impact the Business Model of Biopharmaceutical firms and assess how ESG pillars can aid in Business Model innovation. Semi-structured personal interviews were conducted in face to face meetings with experienced industry professionals from cross-functional domains to attain diverse insights. The objective was to explore the relevance of ESG factors and their interplay, during Business Model Innovation from the perspective of experts in the Biopharmaceutical industry. Analytical Hierarchy Process (AHP) – a structured approach is applied to understand the criticality of various factors in sustainable business models. The study revealed that special emphasis should be laid on the Business Model and Governance Pillar – for re-designing innovative and sustainable business models. Social and Environment factors, although important, were rated lower on priority as such issues are usually focused upon by organizations at a higher level of maturity, after the basic hygiene factors are met. Some of the factors which were prioritized for Business Model innovation are Patient Health and Safety, Ethical marketing and advertising, Waste/ Effluent Management, Employee Health, Safety and Wellness, Patient value propositions, Building strategic resources and competencies, Product Quality & Safety and Business ethics and competitive behavior. Integrated reporting is another value-added dimension that was stressed by the respondents, to have a seamless and transparent communication channel established with all stakeholders. Aligning business metrics with ESG metrics is the focal point of this study, and the impact of each pillar on Biopharma Business Models was evaluated by industry experts. Integration of ESG parameters for Business Model Innovation is the new mantra for forward looking companies, and this study would help frame strategies for the Biopharma industry for sustainable value creation. The impact created by Business Model Innovation at an industry level will help create value for the society at large (who are the key beneficiaries of Biopharma products and services), and such studies would help add to the knowledge base.\",\"PeriodicalId\":45715,\"journal\":{\"name\":\"Australasian Accounting Business and Finance Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Australasian Accounting Business and Finance Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14453/aabfj.v17i1.12\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BUSINESS, FINANCE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australasian Accounting Business and Finance Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14453/aabfj.v17i1.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BUSINESS, FINANCE","Score":null,"Total":0}
引用次数: 0

摘要

本研究探讨了影响生物制药公司商业模式的关键因素,并评估了ESG支柱如何帮助商业模式创新。与来自跨职能领域的经验丰富的行业专业人士进行面对面的半结构化个人访谈,以获得不同的见解。目的是从生物制药行业专家的角度探讨商业模式创新过程中ESG因素的相关性及其相互作用。层次分析法(AHP)——一种结构化的方法,用于理解可持续商业模式中各种因素的重要性。研究显示,应特别重视商业模式和管治支柱,重新设计创新和可持续的商业模式。社会和环境因素虽然重要,但在优先级上被评为较低,因为在基本卫生因素得到满足之后,这些问题通常由成熟度较高的组织关注。商业模式创新优先考虑的一些因素是患者健康和安全、道德营销和广告、废物/污水管理、员工健康、安全和健康、患者价值主张、建立战略资源和能力、产品质量和安全以及商业道德和竞争行为。综合报告是受访者强调的另一个增值维度,即与所有利益相关者建立无缝和透明的沟通渠道。将业务指标与ESG指标相结合是本研究的重点,每个支柱对生物制药商业模式的影响由行业专家进行了评估。将ESG参数整合到商业模式创新中是前瞻性公司的新口头语,本研究将有助于构建生物制药行业可持续价值创造的战略框架。商业模式创新在行业层面上的影响将有助于为整个社会创造价值(他们是生物制药产品和服务的主要受益者),此类研究将有助于增加知识基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Integrating ESG Pillars for Business Model Innovation in the Biopharmaceutical Industry
The study explores critical factors that impact the Business Model of Biopharmaceutical firms and assess how ESG pillars can aid in Business Model innovation. Semi-structured personal interviews were conducted in face to face meetings with experienced industry professionals from cross-functional domains to attain diverse insights. The objective was to explore the relevance of ESG factors and their interplay, during Business Model Innovation from the perspective of experts in the Biopharmaceutical industry. Analytical Hierarchy Process (AHP) – a structured approach is applied to understand the criticality of various factors in sustainable business models. The study revealed that special emphasis should be laid on the Business Model and Governance Pillar – for re-designing innovative and sustainable business models. Social and Environment factors, although important, were rated lower on priority as such issues are usually focused upon by organizations at a higher level of maturity, after the basic hygiene factors are met. Some of the factors which were prioritized for Business Model innovation are Patient Health and Safety, Ethical marketing and advertising, Waste/ Effluent Management, Employee Health, Safety and Wellness, Patient value propositions, Building strategic resources and competencies, Product Quality & Safety and Business ethics and competitive behavior. Integrated reporting is another value-added dimension that was stressed by the respondents, to have a seamless and transparent communication channel established with all stakeholders. Aligning business metrics with ESG metrics is the focal point of this study, and the impact of each pillar on Biopharma Business Models was evaluated by industry experts. Integration of ESG parameters for Business Model Innovation is the new mantra for forward looking companies, and this study would help frame strategies for the Biopharma industry for sustainable value creation. The impact created by Business Model Innovation at an industry level will help create value for the society at large (who are the key beneficiaries of Biopharma products and services), and such studies would help add to the knowledge base.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.90
自引率
15.80%
发文量
22
审稿时长
24 weeks
期刊介绍: The Australasian Accounting, Business and Finance Journal is a double blind peer reviewed academic journal. The main focus of our journal is to encourage research from areas of social and environmental critique, exploration and innovation as well as from more traditional areas of accounting, finance, financial planning and banking research. There are no fees or charges associated with submitting to or publishing in this journal.
期刊最新文献
THE INFLUENCE OF BRAND SIGNATURE, AWARENESS, ATTITUDE, AND REPUTATION ON PRIMEBIZ HOTEL SURABAYA’S BRAND PERFORMANCE Community Participation In Developing Cupak Village As A Tourist Destination In Jombang, East Java, Indonesia Modeling E-Commerce Website Using QFD Digital Twin Technology: A Scoping Review of Characterization and Implementation Through Business IT Perspectives Analysis of The Benefits of Financial Technology and Financial Socialization Towards Financial Behavior in Students in Surabaya Post Pandemic with Financial Literacy as The Intervening Variable
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1